Real World Evidence of CAR T-Cell Therapies for the Treatment of Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma: A Monocentric Experience

SIMPLE SUMMARY: CAR T-cell therapies have undoubtedly revolutionized the treatment of relapsed/refractory B-cell non-Hodgkin lymphoma. These therapies represent a valuable new treatment option, yielding impressive complete remission rates and improving survival. The aim of this article is to give an...

Descripción completa

Detalles Bibliográficos
Autores principales: Casadei, Beatrice, Argnani, Lisa, Guadagnuolo, Serafina, Pellegrini, Cinzia, Stefoni, Vittorio, Broccoli, Alessandro, Nanni, Laura, Morigi, Alice, Lolli, Ginevra, Guarino, Maria, Spinardi, Luca, Pierucci, Elisabetta, Fanti, Stefano, Bartoletti, Michele, Dicataldo, Michele, Sabattini, Elena, Bonifazi, Francesca, Zinzani, Pier Luigi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8507677/
https://www.ncbi.nlm.nih.gov/pubmed/34638273
http://dx.doi.org/10.3390/cancers13194789

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8507677/
https://www.ncbi.nlm.nih.gov/pubmed/34638273
http://dx.doi.org/10.3390/cancers13194789

Ejemplares similares